EDN1 and cardiac hypertrophy: Interestingly, induction of hypertrophy by endothelin-1 treatment significantly reduced levels of miR-590-5p and miR-590-3p in IPSC-CMs (p-value < 0.003 and < 0.002, respectively) (Fig 6), suggesting a possible role for miR-590 in cardiac hypertrophy.